Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 13 clinical trials
Etoposide and Cisplatin in Treating Young Patients With Previously Untreated High-Risk Neuroblastoma Undergoing High-Dose Chemotherapy Stem Cell Transplant and Isotretinoin

, stem cell transplant, and isotretinoin.

melphalan
cyclophosphamide
x-rays
conventional surgery
stem cell transplantation
  • 24 views
  • 07 Nov, 2020
  • 1 location
Efficacy and Safety of 1565-nm Non-ablative Fractional Laser Versus Long-pulsed 1064-nm Nd:YAG Laser in the Treatment of Enlarged Facial Pores

Facial pores are visible openings of pilosebaceous follicles, it is one of the important factors that affect the appearance of facial skin. This study aims to evaluate and compare the Efficacy and safety of 1565 nm non-ablative fractional laser (NAFL) and long-pulsed 1064 nm Nd:YAG laser (LPNY) in the treatment …

Accepts healthy volunteers
  • 0 views
  • 10 May, 2022
Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

This phase II trial studies if dinutuximab, GM-CSF, isotretinoin in combination with irinotecan, and temozolomide (chemo-immunotherapy) can be given safely to patients with high-risk

  • 0 views
  • 25 May, 2022
  • 36 locations
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)

therapy followed by peripheral blood stem cell rescue, radiotherapy to the site of the primary tumour and immunotherapy (R4 randomization - isotretinoin and ch14.18/CHO (Dinutuximab beta, Qarziba

interleukin
melphalan
topotecan
monoclonal antibody ch14.18
mycn protein
  • 308 views
  • 26 Jan, 2021
  • 126 locations
Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

This phase III trial studies iobenguane I-131 or crizotinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, such as iobenguane I-131, may carry radiation directly to tumor cells and not harm normal cells. Crizotinib may stop the growth of tumor cells by blocking …

melphalan
topotecan
conventional surgery
mycn protein
stem cell transplantation
  • 117 views
  • 01 Mar, 2022
  • 102 locations
Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI

. Moderate and severe reactions requiring systemic therapy, usually tetracycline antibiotics or isotretinoin. No randomized trial has compared the relative effectiveness of tetracyclines versus isotretinoin

  • 0 views
  • 15 Sep, 2021
  • 1 location
Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for Moderate and Severe Acne Vulgaris

conventional dose of oral isotretinoin for treatment of moderate or severe acne vulgaris. The hypothesis is that the painless ALA- PDT will be equally or more efficacious as oral isotretinoin, and taking

photodynamic therapy
isotretinoin
aminolevulinic acid
  • 35 views
  • 18 Feb, 2022
  • 1 location
Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission.

enrolled to receive naxitamab + GM-CSF in combination with isotretinoin.

isotretinoin
high-risk neuroblastoma
colony stimulating factor
  • 0 views
  • 22 Mar, 2022
  • 4 locations
Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. (FASCE)

triglycerides, cholesterol and hepatic balance. The last alternative is represented by isotretinoin but the use in women of childbearing potential is binding because of the teratogen risks and the

isotretinoin
acne treatment
androgens
antibiotics
doxycycline
  • 1148 views
  • 01 Feb, 2022
  • 6 locations
High Dose Chemotherapy and Autologous Transplant for Neuroblastoma

This is a standard of care document, outlining the therapy for children with high risk neuroblastoma who are not eligible for Children's Oncology Group (COG) studies.

shortening fraction
high dose chemotherapy
monoclonal antibody ch14.18
granulocyte colony stimulating factor
melphalan
  • 5 views
  • 21 Apr, 2022
  • 1 location